CNA

CNA Financial (CNA) Is Up - What Are Investors Seeing in This Stock?

Shares of CNA Financial rose to $46.8 during today's afternoon trading session. Despite the 8.0% change, the large-cap Property & Casualty Insurance company still trades 10.12% above its average analyst target price of $42.5. So there may be further downside for the Property & Casualty Insurance stock. CNA Financial has target prices ranging from $39.0 to $46.0 per share, and its average rating is hold.

The stock has a very low short interest at 1.3%, and a short ratio of 1.51. The company's insiders own 0.27% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 98.9% of CNA Financial's shares being owned by this investor type.

Institutions Invested in CNA Financial

Date Reported Holder Percentage Shares Value
2023-09-30 Loews Corporation 92% 248,414,738 $11,625,809,548
2023-09-30 JP Morgan Chase & Company 1% 1,381,187 $64,639,550
2023-09-30 Blackrock Inc. 0% 1,368,022 $64,023,428
2023-09-30 Lsv Asset Management 0% 1,154,589 $54,034,764
2023-12-31 River Road Asset Management, LLC 0% 1,046,427 $48,972,782
2023-09-30 Smith (Donald) & Company Inc. 0% 979,019 $45,818,088
2023-12-31 Private Management Group, Inc. 0% 871,390 $40,781,051
2023-09-30 Dimensional Fund Advisors LP 0% 753,045 $35,242,505
2023-12-31 Bank Of New York Mellon Corporation 0% 760,507 $35,591,727
2023-09-30 Vanguard Group Inc 0% 677,110 $31,688,747

Besides an analyst belief that shares are overpriced, other market factors point to there being mixed market sentiment on CNA Financial.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS